Difference and clinical value of metabolites in plasma and feces of patients with alcohol-related liver cirrhosis.

Background: Alterations in plasma and intestinal metabolites contribute to the pathogenesis and progression of alcohol-related liver cirrhosis (ALC).

Aim: To explore the common and different metabolites in the plasma and feces of patients with ALC and evaluate their clinical implications.

Methods: According to the inclusion and exclusion criteria, 27 patients with ALC and 24 healthy controls (HCs) were selected, and plasma and feces samples were collected.